Progesterone vaginal ring

DRUG2 trials

Sponsors

Ferring Pharmaceuticals, Grünenthal GmbH

Conditions

PharmacokineticsProgesterone Supplementation in Women Undergoing ART

Phase 1

Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women

CompletedNCT03737656

Grünenthal GmbHPharmacokinetics

Start: 2018-11-01End: 2019-05-09Updated: 2019-06-05

Phase 3

Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures

CompletedNCT03565211

Ferring PharmaceuticalsProgesterone Supplementation in Women Undergoing ART

Start: 2018-07-26End: 2019-07-29Updated: 2020-11-23

Related Papers

Safety evaluation of a novel progesterone vaginal ring (PVR) for luteal phase support: SARA trial

Drug Delivery and Translational Research2026-05-29